KATZ KAREN

SEC source: 0001157619-26-000014 · wk-form4_1790885677.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,145

F1 · security: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

F2 · shares: The DRSUs were granted to the Reporting Person on September 30, 2026 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person.

SEC source: 0001157619-26-000012 · wk-form4_1785357200.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,883

F1 · security: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

F1 · shares: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

SEC source: 0001157619-26-000009 · wk-form4_1782939214.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 239,733

F1 · security: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

F2 · shares: The DRSUs were granted to the Reporting Person on June 30, 2026 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person.

SEC source: 0001157619-26-000007 · wk-form4_1775160898.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,355

F1 · security: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

F2 · shares: The DRSUs were granted to the Reporting Person on March 31. 2026 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person.

SEC source: 0001157619-26-000003 · form4.xml · derivative · entry 2

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,627

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

SEC source: 0001157619-26-000003 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124

Underlying: Humana Common · 49 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

SEC source: 0001157619-26-000005 · wk-form4_1767820792.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,367

F1 · security: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

F2 · shares: The DRSUs were granted to the Reporting Person on December 31,2025 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person.

SEC source: 0001157619-25-000010 · wk-form4_1759350012.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 235,260

F1 · security: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

F2 · shares: The DRSUs were granted to the Reporting Person on September 30,2025 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person.

SEC source: 0001157619-25-000008 · wk-form4_1753482249.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,732

F1 · shares: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

SEC source: 0001336917-25-000124 · wk-form4_1751574015.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,479.75

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.

SEC source: 0001157619-25-000006 · wk-form4_1751400692.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,707

F1 · security: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

F2 · shares: The DRSUs were granted to the Reporting Person on June 30,2025 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person.

SEC source: 0001336917-25-000038 · wk-form4_1743631011.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,141.47

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.

SEC source: 0001573221-25-000024 · edgardoc.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,315

F1 · security: Represents shares of TheRealReal, Inc. common stock that will be issued to the Reporting Person upon settlement of deferred restricted stock units (DRSUs). Each DRSU is the economic equivalent of one share of TheRealReal, Inc. common stock.

F2 · shares: The DRSUs were granted to the Reporting Person on March 31,2025 pursuant to TheRealReal Inc. 2019 Equity Incentive Plan and are fully vested. The DRSUs are deferred and generally will be settled upon the Reporting Persons separation from service as a Non-Employee Director of the TheRealReal Inc. or a date elected by the Reporting Person.

SEC source: 0001062993-25-000099 · form4.xml · derivative · entry 2

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,861

Underlying: Humana Common · 783 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

SEC source: 0001336917-25-000006 · wk-form4_1736200500.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,452.95

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.

SEC source: 0001062993-25-000099 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75

Underlying: Humana Common · 38 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

SEC source: 0001336917-24-000159 · wk-form4_1727915707.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,362.29

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.

SEC source: 0001336917-24-000137 · wk-form4_1725583238.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,670.9

F1 · security: Annual restricted stock unit grant pursuant to the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.

SEC source: 0001573221-24-000115 · edgardoc.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,301

F1 · shares: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $2.590 to $2.669. Reporting Person undertakes to provide TheRealReal, Inc., any security holder of TheRealReal, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

SEC source: 0001573221-24-000096 · edgardoc.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,301

F1 · kind: These restricted stock units ("RSUs") vest on the earlier of (a) the first anniversary of the grant date of such award or (b) the date immediately preceding the next annual meeting of Companys stockholders, subject to the non-employee directors continued service through the applicable vesting date.

SEC source: 0001336917-24-000107 · wk-form4_1719967906.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,683.56

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2025 Non-Employee Director Compensation Plan.

SEC source: 0001336917-24-000051 · wk-form4_1712103914.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,151.38

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2024 Non-Employee Director Compensation Plan.

SEC source: 0001573221-24-000044 · edgardoc.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,476

SEC source: 0001573221-24-000048 · edgardoc.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,376

F1 · shares: The original Form 4 filed on March 8, 2024 is amended by this Form 4 amendment to reflect a purchase of 6,400 shares rather than the 6,500 shares originally reported.

SEC source: 0001062993-24-000110 · form4.xml · derivative · entry 5

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430

Underlying: Humana Common · 430 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.

SEC source: 0001336917-24-000011 · wk-form4_1704331601.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,946.25

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2024 Non-Employee Director Compensation Plan.

SEC source: 0001062993-24-000110 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37

Underlying: Humana Common · 17 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

SEC source: 0001209191-23-051925 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,212.35

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. Fiscal Year 2024 Non-Employee Director Compensation Plan.

SEC source: 0001209191-23-047739 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,600.79

F1 · security: Annual restricted stock unit grant pursuant to the Under Armour, Inc. Fiscal Year 2024 Non-Employee Director Compensation Plan.

SEC source: 0001573221-23-000063 · edgardoc.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,976

F1 · kind: These restricted stock units ("RSUs") vest on the earlier of (a) the first anniversary of the grant date of such award or (b) the date immediately preceding the next annual meeting of Companys stockholders, subject to the non-employee directors continued service through the applicable vesting date.

SEC source: 0001209191-23-041052 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,986.96

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan.

SEC source: 0001209191-23-022752 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,678.14

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan.

SEC source: 0001062993-23-000412 · form4.xml · derivative · entry 5

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380

Underlying: Humana Common · 380 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/23.

SEC source: 0001209191-23-001266 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,472.26

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan.

SEC source: 0001062993-23-000412 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20

Underlying: Humana Common · 10 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

SEC source: 0001209191-22-052368 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,363.15

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan.

SEC source: 0001573221-22-000084 · edgardoc.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,029

F1 · shares: These restricted stock units ("RSUs") vest on the earlier of the first anniversary of the grant date or the date immediately preceding the Issuers next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date and subject to acceleration upon certain events.

SEC source: 0001209191-22-041088 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,405.74

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan.

SEC source: 0001209191-22-028564 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,961.15

F1 · security: Annual restricted stock unit grant pursuant to the Under Armour, Inc. Fiscal Year 2023 Non-Employee Director Compensation Plan.

SEC source: 0001209191-22-022332 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,558.54

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan.

SEC source: 0001598674-22-000023 · wf-form4_164323142465983.xml · derivative · entry 2

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,000 shares

Expires 2029-04-10

F4 · price: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.

F3 · derivative.exercise_date: The options provided for vesting in equal monthly installments over a four year period commencing on May 11, 2019, and would have been fully vested and exercisable on April 11, 2023.

SEC source: 0001598674-22-000023 · wf-form4_164323142465983.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.

F2 · price: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.

SEC source: 0001598674-22-000009 · wf-form4_164254198653055.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,012

F1 · shares: Represents 1,619 deferred stock units received in lieu of cash compensation for service as a director pursuant to an election made by the Reporting Person. Each deferred stock unit will settle in full 90 days after the Reporting Person ceases to serve on the Company's Board of Directors.

SEC source: 0001062993-22-000097 · form4.xml · derivative · entry 5

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 412

Underlying: Humana Common · 412 shares

Expires not disclosed

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/22.

SEC source: 0001209191-22-001465 · doc4.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,340.22

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan.

SEC source: 0001062993-22-000097 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10

Underlying: Humana Common · 7 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

SEC source: 0001062993-22-000097 · form4.xml · derivative · entry 3

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 535

Underlying: Humana Common · 22 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

SEC source: 0001598674-21-000085 · wf-form4_163467541316112.xml · nonDerivative · entry 1

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,393

F1 · shares: Represents 2,345 deferred stock units received in lieu of cash compensation for service as a director pursuant to an election made by the Reporting Person. Each deferred stock unit will settle in full 90 days after the Reporting Person ceases to serve on the Company's Board of Directors.

SEC source: 0001246360-21-000941 · form.xml · nonDerivative · entry 2

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,025.89

F1 · security: Director fees deferred as deferred stock units pursuant to the Under Armour, Inc. 2006 Non-Employee Director Deferred Stock Unit Plan.

SEC source: 0000049071-21-000128 · edgar.xml · derivative · entry 3

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 513

Underlying: Humana Common · 72 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).